Detalhe da pesquisa
1.
Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
Prostate
; 84(8): 772-779, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504659
2.
US-guided high-intensity focused ultrasound in pancreatic cancer treatment: a consensus initiative between Chinese and European HIFU centers.
Int J Hyperthermia
; 41(1): 2295812, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159562
3.
Lack of repeatability of radiomic features derived from PET scans: Results from a 18 F-DCFPyL test-retest cohort.
Prostate
; 83(6): 547-554, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632656
4.
Test-retest repeatability of organ uptake on PSMA-targeted 18 F-DCFPyL PET/CT in patients with prostate cancer.
Prostate
; 83(12): 1186-1192, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37211963
5.
Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts.
Alzheimers Dement
; 19(11): 4922-4934, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070734
6.
Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma.
Int J Mol Sci
; 24(15)2023 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37569852
7.
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL.
Mol Imaging
; 2022: 7056983, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35283693
8.
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy.
Prostate
; 82(14): 1406-1412, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35860909
9.
Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging
; 49(9): 3269-3276, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243517
10.
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease.
Eur J Nucl Med Mol Imaging
; 49(13): 4727-4735, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852555
11.
No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in Germany.
BMC Cancer
; 21(1): 526, 2021 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33971845
12.
The value of tumor markers in men with metastatic prostate cancer undergoing [177 Lu]Lu-PSMA therapy.
Prostate
; 80(1): 17-27, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31579967
13.
Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-CTLA-4 therapy by bioinformatics.
Invest New Drugs
; 38(6): 1717-1729, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32500465
14.
Programmed cell death protein 1 (PD-1)-inhibition in hepatocellular carcinoma (HCC): a single center experience.
Scand J Gastroenterol
; 55(9): 1057-1062, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32692941
15.
Manual vs automated 68 Ga-radiolabelling-A comparison of optimized processes.
J Labelled Comp Radiopharm
; 63(4): 162-173, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31845408
16.
DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis-Challenges and Critical Points in Implementation into Clinical Routine.
Molecules
; 25(13)2020 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32629930
17.
68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging
; 46(5): 1054-1062, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30697649
18.
Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer.
Eur J Nucl Med Mol Imaging
; 46(5): 1073-1080, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30474706
19.
Quality of life in patients with midgut NET following peptide receptor radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 46(11): 2252-2259, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338547
20.
Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and safety according to prior use of chemotherapy in routine clinical practice.
Eur J Nucl Med Mol Imaging
; 46(5): 1102-1110, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30637501